Aldeyra Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Lexington, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Aldeyra Therapeutics, Inc. has filed 645 SEC EDGAR filings since 06 Oct 2005

SEC filing history

Showing 101-125 of 643 matching filings.

Per page
25
Current page
5
DEF 14A File 001-36332

DEF 14A

Filing date
22 Apr 2024
Reporting date
04 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A

Filing date
17 Apr 2024
Reporting date
12 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A

Filing date
17 Apr 2024
Reporting date
11 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
08 Apr 2024
Reporting date
04 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
03 Apr 2024
Reporting date
01 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

CURRENT REPORT

Filing date
28 Mar 2024
Reporting date
28 Mar 2024
Next action
Verify source filing
UPLOAD File 333-277753

UPLOAD filing

Filing date
13 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Mar 2024
Reporting date
09 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Mar 2024
Reporting date
09 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Mar 2024
Reporting date
09 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36332

144 filing

Filing date
12 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36332

144 filing

Filing date
11 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36332

144 filing

Filing date
11 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36332

144 filing

Filing date
11 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-277753

S-3

Filing date
07 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-277752

S-8

Filing date
07 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-275315

S-8 POS

Filing date
07 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88182

SC 13G/A

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88182

SCHEDULE 13G

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date
13 Feb 2024
Reporting date
13 Feb 2024
Next action
Verify source filing
SC 13G File 005-88182

SC 13G filing

Filing date
29 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date
04 Jan 2024
Reporting date
04 Jan 2024
Next action
Verify source filing
8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date
19 Dec 2023
Reporting date
19 Dec 2023
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .